Compare KHC & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KHC | WST |
|---|---|---|
| Founded | 1869 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.8B | 25.8B |
| IPO Year | 2015 | 2004 |
| Metric | KHC | WST |
|---|---|---|
| Price | $24.94 | $353.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 7 |
| Target Price | $24.50 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 12.5M | 694.8K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | ★ 7.14% | 0.30% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | 0.67 | ★ 1.92 |
| Revenue | ★ $24,942,000,000.00 | $2,886,900,000.00 |
| Revenue This Year | N/A | $6.76 |
| Revenue Next Year | $0.58 | $6.22 |
| P/E Ratio | ★ $37.22 | $184.97 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $21.04 | $206.80 |
| 52 Week High | $29.19 | $367.66 |
| Indicator | KHC | WST |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 64.99 |
| Support Level | $23.30 | $259.17 |
| Resistance Level | $25.86 | N/A |
| Average True Range (ATR) | 0.61 | 7.51 |
| MACD | 0.15 | -0.05 |
| Stochastic Oscillator | 71.93 | 72.27 |
In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for around 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.